FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Medical Devices

FDA Approves Medtronics CoreValve Evolut Valve

FDA approves a Medtronic PMA for the CoreValve Evolut PRO valve for treating severe aortic stenosis for symptomatic patients who are at high or extrem...

Stakeholders Suggest Drug-Device Product Guidance Changes

Two stakeholders say an FDA draft guidance on comparative analyses and related comparative use human factor studies in ANDAs for drug-device combinati...

Human Drugs

GAO to Investigate Orphan Drugs

Sens. Hatch, Grassley, and Cotton ask the Government Accountability Office to determine if drug and biotech companies are abusing FDAs orphan drug pro...

Human Drugs

FDA Draft Guide on Delayed Graft Function in Kidney Transplants

FDA releases a draft guidance on Delayed Graft Function in Kidney Transplantation: Developing Drugs for Prevention.

Human Drugs

Compounding Pharmacy Owner Convicted in 2012 Meningitis Outbreak

A federal court jury convicts former New England Compounding Center co-owner Barry Cadden of racketeering and other charges stemming from a 2012 fatal...

Marketing

Proposed Deceptive Ad Studies Have Little Practical Use: PhRMA

PhRMA questions the usefulness of two proposed FDA consumer/healthcare professional studies on deceptive prescription drug advertising.

Medical Devices

FDA Opens Infectious Disease Sequencing Web Site

FDA launches a Web site to support advancement of infectious disease next generation sequencing technology.

Federal Register

Conference on Generic Drug Development

Federal Register notice: FDA announces a two-day (4/4-5) public conference entitled FDA CDER Small Business and Industry Assistance (SBIA) Regulatory ...

Human Drugs

Trump Administration Abandoning User Fee Agreements

FDA testimony on Capitol Hill indicates that the Trump Administration does not stand behind agency- and industry-negotiated user fee agreements and th...

Human Drugs

CGMP Violations at Indias USV Private Limited

FDA warns USV Private Limited about CGMP violations in its production of finished pharmaceuticals at a facility in Mumbai, India.